Novo Nordisk, Akero Therapeutics plan to file HSR paperwork by Nov. 7
Novo Nordisk and Akero Therapeutics plan to file the Hart-Scott-Rodino paperwork for their $5.2 billion deal by Nov. 7, according to a securities filing from Akero. The filing would start a...To view the full article, register now.
Already a subscriber? Click here to view full article